2025
Information Needs for Opioid Use Disorder Treatment Using Buprenorphine Product: Qualitative Analysis of Suboxone-Focused Reddit Data
Basak M, Sharif O, Lord S, Borodovsky J, Marsch L, Springer S, Nunes E, Brackett C, Archibald L, Preum S. Information Needs for Opioid Use Disorder Treatment Using Buprenorphine Product: Qualitative Analysis of Suboxone-Focused Reddit Data. Journal Of Medical Internet Research 2025, 27: e68886. PMID: 40489766, PMCID: PMC12186000, DOI: 10.2196/68886.Peer-Reviewed Original ResearchConceptsLarge-scale dataPotential rumorsSocial media platformsReddit postsInformation needsOpioid use disorder treatmentOpioid use disorderMedia platformsUse disorderDisorder treatmentRedditSocial mediaHypothesis generationInformationFood and Drug Administration-approved medicationsClinical expertsFrequent topicTreatment informationSubstance useFrom embedded interprofessional clinics to expanded alcohol-associated liver disease programs.
Winder G, Arab J, Goswami Banerjee A, Bryce K, Fipps D, Hussain F, Im G, Omary L, Patel A, Patel S, Rubman S, Serper M, Shenoy A, Suzuki J, Zimbrean P, Brown K, Abouljoud M, Mellinger J. From embedded interprofessional clinics to expanded alcohol-associated liver disease programs. Liver Transplantation 2025 PMID: 40359009, DOI: 10.1097/lvt.0000000000000638.Peer-Reviewed Original ResearchAlcohol-associated liver diseaseAUD careLong-term patient relationshipsCare delivery strategiesHazardous alcohol usePatient populationInterprofessional clinicPalliative carePrimary careCare elementsCare frameworkIll patient populationPatient relationshipHealthcare systemLiver transplantationHarm reductionDisease programsCareAlcohol useLiver diseaseEnhanced supportChronic liver diseaseEating disorder treatmentCollaborative modelDisorder treatmentStructural Brain Changes Associated With Cognitive Behavioral Therapy in Cocaine Use Disorder Treatment
McCurdy L, DeVito E, Loya J, Nich C, Kiluk B, Potenza M. Structural Brain Changes Associated With Cognitive Behavioral Therapy in Cocaine Use Disorder Treatment. Drug And Alcohol Dependence 2025, 267: 112224. DOI: 10.1016/j.drugalcdep.2024.112224.Peer-Reviewed Original Research
2024
The Need to Increase Help‐Seeking for Eating Disorders in General and Binge‐Eating Disorder Specifically: Commentary on Ali et al.'s (2024) Meta‐Analysis
Lydecker J. The Need to Increase Help‐Seeking for Eating Disorders in General and Binge‐Eating Disorder Specifically: Commentary on Ali et al.'s (2024) Meta‐Analysis. International Journal Of Eating Disorders 2024, 58: 514-517. PMID: 39723480, PMCID: PMC11893227, DOI: 10.1002/eat.24364.Peer-Reviewed Original ResearchComparing the Psychometric Properties of Reward and Relief Drinking Measures
Votaw V, Pearson M, Kranzler H, Roos C, Yeater E, Witkiewitz K. Comparing the Psychometric Properties of Reward and Relief Drinking Measures. Experimental And Clinical Psychopharmacology 2024, 32: 664-681. PMID: 38900509, PMCID: PMC11892700, DOI: 10.1037/pha0000716.Peer-Reviewed Original ResearchEcological momentary assessmentDrinking measuresPsychometric propertiesMomentary assessmentConcurrent validityAlcohol use disorder treatmentResponse to naltrexoneProperties of rewardsAlcohol Use Disorders Identification TestWithin-person associationsAlcohol use disorderDisorders Identification TestInternal consistency reliabilityReward drinkingTest-retest reliabilityAcamprosate treatmentAlcohol cravingRelief drinkingAversive statesFindings to clinical practiceCommunity sampleUse disorderPharmacotherapy outcomesDisorder treatmentAlcohol useAn Urgent Need to Promote Equitable Buprenorphine Administration for Opioid Use Disorder in the Emergency Department
Coupet E, Edelman E. An Urgent Need to Promote Equitable Buprenorphine Administration for Opioid Use Disorder in the Emergency Department. Journal Of Addiction Medicine 2024, 19: 1-3. PMID: 39899674, DOI: 10.1097/adm.0000000000001409.Peer-Reviewed Original ResearchBuprenorphine administrationOpioid use disorder treatmentOpioid use disorderUse disorderAddiction treatmentDisorder treatmentEmergency departmentED patientsCross-sectional study of ED patientsTreatment accessBuprenorphineStudy of ED patientsOpioidOpioid overdose deathsOpioid misuseOverdose deathsCross-sectional studyLatinosAddictionExamining the impact of brief couples‐based posttraumatic stress disorder treatments on anger and psychological aggression in veterans and their partners
Wells S, Knopp K, Wachsman T, Dillon K, Walker H, Sippel L, Morland L, Glassman L. Examining the impact of brief couples‐based posttraumatic stress disorder treatments on anger and psychological aggression in veterans and their partners. Journal Of Traumatic Stress 2024, 38: 165-173. PMID: 39318041, PMCID: PMC11794020, DOI: 10.1002/jts.23099.Peer-Reviewed Original ResearchPosttraumatic stress disorderPsychological aggressionCouples-based interventionsCognitive-behavioral conjoint therapyPosttraumatic stress disorder treatmentIntimate partnersVeterans' mental healthAngry temperamentInterpersonal functioningConjoint therapyAnger symptomsStress disorderDisorder treatmentAngerEffect sizeMental healthAggressionVeteransTreatment conditionsActive comparatorPosttreatmentImprove aspectsLoved onesTemperamentPartnersMultiscale Neuroimaging Features for the Identification of Medication Class and Non-Responders in Mood Disorder Treatment
Baker B, Salman M, Fu Z, Iraji A, Osuch E, Bockholt H, Calhoun V. Multiscale Neuroimaging Features for the Identification of Medication Class and Non-Responders in Mood Disorder Treatment. 2024, 00: 1-5. DOI: 10.1109/isbi56570.2024.10635741.Peer-Reviewed Original ResearchTreatment of mood disordersMood disordersCourse of antidepressantsFunctional network connectivity measuresMedication classesMood disorder treatmentNeuroimaging featuresComplex behavioral symptomsNetwork connectivity measuresMood stabilizersNon-respondersBehavioral symptomsDisorder treatmentNeuroimaging scansResting state functional networksNeural featuresConnectivity measuresFunctional networksMoodDisordersEffective courseAntidepressantsClinical decision supportClinical treatmentSymptoms“Recovery is about change, so you have to change everything”: Exploring the evolution of recovery capital among women in substance use disorder treatment
Jadovich E, Viera A, Edelman E, Muilenburg J, Kershaw T. “Recovery is about change, so you have to change everything”: Exploring the evolution of recovery capital among women in substance use disorder treatment. SSM - Qualitative Research In Health 2024, 5: 100422. PMID: 40060368, PMCID: PMC11883845, DOI: 10.1016/j.ssmqr.2024.100422.Peer-Reviewed Original ResearchSubstance use disorder treatmentRecovery capitalSecondary qualitative analysis of dataDisorder treatmentNon-clinical interventionsCommunity capitalSubstance use disordersSecondary qualitative analysisSubstance use disorder recoveryIndirect effects of treatmentExperiences of womenEffects of treatmentSubstance use researchRecovery capital frameworkAddiction researchQualitative analysis of dataStudy time pointsThematic analysisClinical pathwayParticipants' experiencesTreatment programsDisorder recoveryWomen's experiencesCapital frameworkCapital developmentCurrent and Future Approaches to Pediatric Anxiety Disorder Treatment
Zugman A, Winkler A, Qamar P, Pine D. Current and Future Approaches to Pediatric Anxiety Disorder Treatment. American Journal Of Psychiatry 2024, 181: 189-200. PMID: 38425255, PMCID: PMC11256210, DOI: 10.1176/appi.ajp.20231037.Peer-Reviewed Original ResearchPromoting Resilience to Improve Disordered Eating (PRIDE): A case series of an eating disorder treatment for sexual minority individuals
Brown T, Klimek‐Johnson P, Siegel J, Convertino A, Douglas V, Pachankis J, Blashill A. Promoting Resilience to Improve Disordered Eating (PRIDE): A case series of an eating disorder treatment for sexual minority individuals. International Journal Of Eating Disorders 2024, 57: 648-660. PMID: 38279188, DOI: 10.1002/eat.24150.Peer-Reviewed Original ResearchED symptomsEating disordersSM individualsED treatmentEnhanced cognitive behaviour therapyED diagnosisCognitive behavioral therapyStress reactionsActive control conditionEating disorder treatmentSexual orientation concealmentSexual minoritiesSexual minority individualsCase seriesFollow-upCBT-EBehavioral therapyBody dissatisfactionDisorder treatmentDisordered eatingPreliminary efficacy resultsWeekly sessionsAssociated with improvementsMixed-methods studyClinical impairmentEffectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation
Dams G, Ketchen B, Burden J, Smith N. Effectiveness of residential treatment services for veterans with substance use disorders: A propensity score matching evaluation. Drug And Alcohol Dependence 2024, 255: 111081. PMID: 38211367, DOI: 10.1016/j.drugalcdep.2024.111081.Peer-Reviewed Original ResearchSymptom improvementResidential treatmentCause mortality risk reductionOne-yearSelf-reported mental health outcomesSubstance use disorder treatmentOne-year followSelf-reported mental healthResidential careUse disorder treatmentSubstance use disordersSample of veteransMental health outcomesService utilizationMortality riskResidential treatment servicesUse disordersHealth outcomesTreatment servicesDisorder treatmentMortality risk reductionTreatment improvementPropensity scoreMental healthStudy period
2023
Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17
Heimer R, Black A, Lin H, Grau L, Fiellin D, Howell B, Hawk K, D'Onofrio G, Becker W. Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17. Drug And Alcohol Dependence 2023, 254: 111040. PMID: 38043226, PMCID: PMC10872282, DOI: 10.1016/j.drugalcdep.2023.111040.Peer-Reviewed Original ResearchConceptsNon-medication treatmentsRelative riskOpioid overdose deathsIncidence rateMOUD treatmentOverdose deathsOpioid use disorder treatmentResults Incidence ratesRetrospective cohort studyDifferent treatment modalitiesPopulation-level effortsUse disorder treatmentFatal opioid poisoningsCohort studyOpioid poisoningTreatment modalitiesConclusion ExposurePoisoning deathsFatal overdosesTreatment exposureDisorder treatmentDeathTreatmentMethadoneRiskAccess challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets
Hsu M, Jung O, Kwan L, Jegede O, Martin B, Malhotra A, Suzuki J. Access challenges to opioid use disorder treatment among individuals experiencing homelessness: Voices from the streets. Journal Of Substance Use And Addiction Treatment 2023, 157: 209216. PMID: 37981243, DOI: 10.1016/j.josat.2023.209216.Peer-Reviewed Original ResearchOpioid use disorderSocioeconomic statusUse disordersCOVID-19 pandemicBuprenorphine/naloxoneActive substance useUse disorder treatmentPercent of participantsActive prescriptionMOUD accessSublingual buprenorphineOUD treatmentTreatment gapTreatment accessMOUDDisorder treatmentBuprenorphineAdverse effectsSubstance useVulnerable populationsIndividual-level factorsMedicationsAccess challengesWhite participantsDisordersResearch Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
Jarrett J, Bratberg J, Burns A, Cochran G, DiPaula B, Dopp A, Elmes A, Green T, Hill L, Homsted F, Hsia S, Matthews M, Ghitza U, Wu L, Bart G. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy. Substance Abuse 2023, 44: 264-276. PMID: 37902032, PMCID: PMC10870734, DOI: 10.1177/08897077231203849.Peer-Reviewed Original ResearchConceptsOpioid use disorderNational Drug Abuse Treatment Clinical Trials NetworkOUD treatmentCommunity pharmaciesDrug Abuse's National Drug Abuse Treatment Clinical Trials NetworkUse disordersOpioid use disorder treatmentFifth of peoplePrimary care settingBenefits of medicationsClinical Trials NetworkUse disorder treatmentHealth service modelClinical service provisionOpioid overdose crisisPatient populationCommunity pharmacy sectorPatient outcomesCare settingsMOUD servicesDisorder treatmentSynthetic opioidsChain pharmaciesTrials NetworkMOUDFacilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial
Muvvala S, Gan G, Morford K, Dziura J, Esserman D, Porter E, Chan P, Cornman D, Reynolds J, Yager J, Fiellin D, Edelman E. Facilitation and Preferred Models for Delivering Substance Use Disorder Treatment in HIV Clinics: Results From a Multisite Randomized Trial. Journal Of Addiction Medicine 2023, 17: e388-e391. PMID: 37934538, PMCID: PMC10726383, DOI: 10.1097/adm.0000000000001192.Peer-Reviewed Original ResearchConceptsOpioid use disorderAlcohol use disorderTobacco use disorderHIV clinicUse disordersAddiction treatmentSubstance use disorder treatmentUse disorder treatmentMaintenance phaseRandomized trialsStaff preferencesImproved outcomesMultisite Randomized TrialImplementation facilitationDisorder treatmentControl phaseClinicCliniciansTreatment modelTreatmentDisordersSignificant differencesInterventionHigher proportionAddiction treatment modelsBuprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration
Gordon A, Saxon A, Kertesz S, Wyse J, Manhapra A, Lin L, Chen W, Hansen J, Pinnell D, Huynh T, Baylis J, Cunningham F, Ghitza U, Bart G, Yu H, Sauer B. Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration. Drug And Alcohol Dependence 2023, 248: 109902. PMID: 37196572, PMCID: PMC10875624, DOI: 10.1016/j.drugalcdep.2023.109902.Peer-Reviewed Original ResearchConceptsOpioid use disorderVeterans Health AdministrationUse disordersHealth AdministrationOpioid use disorder treatmentHalf of patientsOpen cohort studyRetention of patientsCourse of careUse disorder treatmentLarge healthcare systemCohort studyMedian durationPatient characteristicsPatient demographicsDaily doseMedication treatmentBuprenorphine useClinical dataWhite racePatientsProportion daysDisorder treatmentMultiple coursesHealthcare systemImplementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial
McCormack R, Rotrosen J, Gauthier P, D'Onofrio G, Fiellin D, Marsch L, Novo P, Liu D, Edelman E, Farkas S, Matthews A, Mulatya C, Salazar D, Wolff J, Knight R, Goodman W, Williams J, Hawk K. Implementing Programs to Initiate Buprenorphine for Opioid Use Disorder Treatment in High-Need, Low-Resource Emergency Departments: A Nonrandomized Controlled Trial. Annals Of Emergency Medicine 2023, 82: 272-287. PMID: 37140493, PMCID: PMC10524047, DOI: 10.1016/j.annemergmed.2023.02.013.Peer-Reviewed Original ResearchConceptsBuprenorphine programImplementation facilitationEmergency departmentMedical recordsOpioid use disorder treatmentMain secondary outcomesMore treatment visitsPrimary implementation outcomeNonrandomized Controlled TrialPatient-level outcomesPatients' medical recordsUse disorder treatmentTreatment 30 daysBuprenorphine administrationOpioid useSecondary outcomesControlled TrialsTreatment visitsED settingUnique patientsClinicians' readinessEligibility criteriaClinical protocolsDisorder treatmentOverdose eventsDoing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States
Cohen S, Tilley J, Yocheved A, Sue K. Doing Our Best in a Broken System: The Urgent Need for Expansion of Medication for Opioid Use Disorder Treatments in the United States. Journal Of Addiction Medicine 2023, 17: 495-496. PMID: 37579123, DOI: 10.1097/adm.0000000000001143.Commentaries, Editorials and LettersMultidisciplinary Management of Opioid Use–Related Infective Endocarditis: Treatment, QTc Values, and Cardiac Arrests due to Ventricular Fibrillation
Rosenfeld L, Jain S, Amabile A, Geirsson A, Krane M, Weimer M. Multidisciplinary Management of Opioid Use–Related Infective Endocarditis: Treatment, QTc Values, and Cardiac Arrests due to Ventricular Fibrillation. Journal Of Clinical Medicine 2023, 12: 882. PMID: 36769531, PMCID: PMC9917424, DOI: 10.3390/jcm12030882.Peer-Reviewed Original ResearchCardiac arrestVentricular fibrillationOpioid useGroup IMOUD useInfective endocarditisYale-New Haven HospitalGroup II patientsCardiac surgeryMultidisciplinary managementQTc prolongationII patientsCS patientsInjection useOpioid epidemicHistorical groupLong-term effectsDisorder treatmentPatientsQTc measurementsQTcHospitalizationEndocarditisSurgeryArrest
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply